IWM
TCRT icon

IHT Wealth Management’s Alaunos Therapeutics TCRT Stock Holding History

IHT Wealth Management’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-77
Closed -$28K – 638
2020
Q1 		$28K Hold
77
– – ﹤0.01% 547
2019
Q4 		$55K Hold
77
– – 0.01% 612
2019
Q3 		$50K Hold
77
– – 0.01% 600
2019
Q2 		$67K Buy
77
+10
+15% +$6.88K 0.01% 530
2019
Q1 		$39K Sell
67
-16
-19% -$6.69K 0.01% 508
2018
Q4 		$23K Buy
+83
New +$32.8K ﹤0.01% 471
2018
Q2 		– Sell
-33
Closed -$19K – 1250
2018
Q1 		$19K Hold
33
– – 0.01% 1002
2017
Q4 		$21K Buy
+33
New +$23.7K 0.01% 981

Other funds holding TCRT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

IHT Wealth Management's TCRT Position: Q2 2020 in Review

IHT Wealth Management sold out of Alaunos Therapeutics (TCRT) in Q2 2020, closing a stake of 77 shares — an estimated $28K sold.

IHT Wealth Management first reported a position in TCRT in Q4 2017 and held it in 8 quarters. The position peaked at $67K in Q2 2019. 146 funds tracked by Wall St. Rank hold TCRT as of Q2 2020.

  • IHT Wealth Management reported no remaining Alaunos Therapeutics position as of Q2 2020 after selling out during the quarter.
  • IHT Wealth Management sold 77 Alaunos Therapeutics shares in Q2 2020, an estimated $28K.
  • IHT Wealth Management first reported a position in Alaunos Therapeutics in Q4 2017 and held it in 8 quarters.
  • IHT Wealth Management's Alaunos Therapeutics position peaked at $67K in Q2 2019.
  • 146 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q2 2020.

Based on IHT Wealth Management's 13F filing for Q2 2020, filed 14 Aug 2020.